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Abstract
Purpose of Review In observational epidemiology, both low
and high birth weights are associated with later type 2 diabe-
tes. The mechanisms underlying the associations are poorly
understood. We review evidence for the roles of genetic and
non-genetic factors linking both sides of the birth weight dis-
tribution to risk of type 2 diabetes, focusing on contributions
made by the most recent genome-wide association studies
(GWAS) of birth weight.
Recent Findings There are now nine genetic loci robustly im-
plicated in both fetal growth and type 2 diabetes. At many of
these, the same alleles are associated both with a higher risk of
type 2 diabetes and a lower birth weight. This supports the
Fetal Insulin Hypothesis and reflects a general pattern for type
2 diabetes susceptibility alleles: genome-wide, there is an in-
verse genetic correlation with birth weight, and initial esti-
mates suggest genetic factors explain a large part of the co-
variance between the two traits. However, the associations at
individual loci show heterogeneity; some fetal risk alleles are
associated with higher birth weight. For most of these, the
association reflects their correlation with the maternal risk
allele which raises maternal glucose, thus increasing fetal
insulin-mediated growth.
Summary GWAS have improved our understanding of the
mechanisms underlying associations between type 2 diabetes
and birth weight but questions remain about the relative im-
portance of genetic versus non-genetic factors and of maternal
versus fetal genotypes. To answer these questions, future work
will require well-powered analyses of parents and offspring.
Keywords Birth weight . Fetal . Genetics . Genome-wide
association study .Maternal . Type 2 diabetes
Introduction
The rising global prevalence of type 2 diabetes presents a
major challenge for human health. Both environmental and
genetic factors contribute to this complex disease. The roles
of obesogenic diet and low physical activity as major adult
risk factors are well established. Moreover, in any given pop-
ulation, there are individuals whose profile of genetic varia-
tion confers greater susceptibility, for example by predispos-
ing to pancreatic beta cell dysfunction. Most of the genetic
variance in type 2 diabetes susceptibility is attributable to var-
iants of common frequency in populations [1•].
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An additional associated factor, which has attracted much
attention during the past 25 years, is birth weight.
Observational studies have consistently reported associations
between type 2 diabetes risk in adulthood and either low or
high birth weight [2–4]. Taken together, these studies support
a U-shaped relationship (Fig. 1), with those individuals at both
extremes of the distribution at greater risk [5]. In this review,
we will consider both sides of the “U” separately and examine
how genetic studies have contributed to our understanding of
the underlying mechanisms. An overview of the mechanisms
involved is presented in Fig. 1.
Evidence that Non-genetic Factors Underlie
the Association Between Lower Birth Weight
and Type 2 Diabetes
The observation that individuals born with lower birth weights
were more likely to have impaired glucose tolerance in
middle-age was first demonstrated 25 years ago [3], and has
since been replicated inmultiple geographically and ethnically
diverse populations. These observations led to the hypothesis
that adverse conditions in utero, for example poor nutrition,
would result not only in reduced fetal growth but also in phys-
iological adaptations that increase susceptibility to poor adult
health [6, 7]. Evidence to support this Developmental Origins
of Health and Disease (DOHaD) hypothesis is reviewed com-
prehensively in [8], but there are two key lines of evidence
from human studies that provide support for non-genetic
mechanisms linking lower birth weight to later life type 2
diabetes risk. First, data from studies of famines (e.g., in the
Netherlands, 1944–5 or China, 1959–61) enable inference to
be made about the long-term effects of exposure to famine
during the gestation period alone. Such studies have shown
that babies born to mothers who were pregnant during famine
had reduced glucose tolerance later in life compared with
those who were in utero outside of famine periods [9, 10].
Second, in a study of monozygotic twins discordant for type
2 diabetes, the affected twins had lower birth weights, on
average, than the unaffected twins, despite sharing the same
genetic predisposition [11].
Evidence that Genetic Factors Underlie
the Association Between Lower Birth Weight
and Type 2 Diabetes
The principle that genetic factors could be important was
established in studies of monogenic diabetes. In 1998,
Hattersley et al. [12] demonstrated that inheriting mutations
in the glucokinase gene (GCK), which reduce glucose sensing
by the pancreas, cause both a reduction in insulin-mediated
fetal growth and hyperglycemia after birth. Based on this and
other rare, monogenic examples of low birth weight with ei-
ther impaired insulin secretion or greater insulin resistance, the
Fetal Insulin Hypothesis was proposed [13]; alleles that pre-
dispose to reduced insulin secretion or raised insulin resis-
tance will both reduce insulin-mediated growth in utero and
increase type 2 diabetes risk in adulthood.
Evidence to support a role for polygenic effects in the link
between type 2 diabetes risk and birth weight has come from
epidemiological studies, e.g., [2, 14], which showed that
Fig. 1 Genetic and non-genetic
factors underlying the
observational association
between birth weight (BW) and
type 2 diabetes (T2D). The plot is
a schematic representation of the
U-shaped relationship resulting
from meta-analysis of multiple
observational studies [5]
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paternal diabetes status is associated with lower birth weight,
while maternal diabetes status is associated with higher birth
weight. Since a father can pass on only genes to the offspring,
and not influence the intrauterine environment in the same way
as the mother (Fig. 2), these observations suggest that inheriting
diabetes susceptibility variants reduces fetal growth.
During the past 10 years, the identification of type 2 diabe-
tes susceptibility variants through genome-wide association
studies (GWAS), coupled with increasingly well-powered ge-
netic studies of birth weight, enabled the first evidence to
emerge that multiple common genetic variants could contrib-
ute both to variation in birth weight and type 2 diabetes risk.
Evidence from candidate gene studies [15–17], and the first
GWAS [18, 19] of birth weight suggested that the type 2
diabetes risk alleles at the CDKAL1, ADCY5, and
HHEX-IDE loci were also associated with lower birth weight.
It is likely that these associations were mediated through their
effects on insulin secretion. The most recent GWAS of birth
weight [20••], in 153,781 individuals, identified 60 loci at
genome-wide significance (here defined as P < 5 × 10−8), nine
of which had also been associated with type 2 diabetes
(Fig. 3). Most of the type 2 diabetes risk alleles at these nine
loci showed associations with lower birth weight. However,
risk alleles atMTNR1B,GCK, and ANK1were associatedwith
higher birth weight.
GWAS Enable Genome-Wide Assessments
of the Genetic Link Between Type 2 Diabetes
and Birth Weight
Genetic variation at the 60 birth weight loci and approximate-
ly 100 type 2 diabetes susceptibility loci explain approximate-
ly 2 and 5–10% of the variation in these traits, respectively.
Assays of common fetal genetic variation across the whole
genome have been estimated collectively to explain 15% of
the variance in birth weight and at least 49% of liability-scale
variance in type 2 diabetes risk [20, 22]. However, it is not
clear what percentage of the covariation between type 2 dia-
betes and birth weight is genetic.
To estimate the overall genetic correlation between type 2
diabetes and birth weight, genome-wide summary statistics
may be combined using a technique known as LD score re-
gression [28•]. This method estimates the shared genetic com-
ponent between the two traits and distinguishes it from con-
founding due to environmental exposures. LD score regres-
sion supports an inverse genetic correlation between birth
weight and type 2 diabetes [20]. In other words, type 2 diabe-
tes risk alleles across the genome also tend to be associated
with lower birth weight. But howmuch of the covariation, i.e.,
the tendency of birth weight and type 2 diabetes risk to track
together, is due to genetics? This question can be tackled using
individual-level data in a mixed model analysis, which en-
ables partitioning of the covariance between the two traits into
genetic and residual components [29]. Initial estimates using
UK Biobank data suggested that a large proportion (96%) of
the covariance was due to shared genetic factors [20], though
the confidence intervals around this estimate were wide.
While genome-wide correlation and covariance estimates
lend support for a substantial role of common genetic effects
contributing to the low birth weight–type 2 diabetes associa-
tion, it is important to consider their limitations. The methods
used assume a linear relationship between the two phenotypes,
which is not strictly applicable to the overall non-linear rela-
tionship that has been observed between type 2 diabetes risk
and birth weight.
The fact that mother and child share 50% of their genes also
means that care must be taken in interpreting estimates of
genetic covariance between birth weight and type 2 diabetes.
The correlation (r ≈ 0.5) between maternal and fetal genotype
means that shared genetic effects are not necessarily directly
attributable to the fetus. Fetal genetic associations may in fact
indicate effects of the intrauterine environment, influenced by
maternal genotype (see Fig. 2). A method for separating these
effects in relation to a single trait has been developed by Eaves
et al. [30•]. The model, called “m-GCTA”, uses both maternal
and fetal genotype to estimate the relative contribution of ma-
ternal vs. fetal genotype to a trait. Applying this to data from
the Avon Longitudinal Study of Parents and Children
(ALSPAC) showed that the maternal genotype contributes
relatively little compared with fetal genotype to variance in
birth weight [20]. It may follow that fetal genotype contributes
to the majority of the covariance between birth weight and
type 2 diabetes, but it has not yet been possible to apply this
method to covariance. Methods that account both for
non-linear relationships andmaternal vs. fetal effects will need
to be applied to large studies of mothers and babies to explore
these genome-wide genetic effects further.
In summary, there is evidence that both genetic and
non-genetic factors underlie the observed association between
Fig. 2 Diagram showing direct and indirect effects of parental genotype
on fetal growth. The mother’s genotype may influence birth weight
directly, by being inherited by the fetus, or indirectly via a primary
effect on the intrauterine environment (e.g., glucose availability). The
father’s genotype cannot influence the intrauterine environment in this
way, so is expected only to influence birth weight directly, once inherited
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lower birth weight and higher risk of type 2 diabetes (Fig. 1,
left side), and initial estimates using GWAS data suggest that
genetic factors play the major role. The associations at three of
the nine loci now robustly implicated in both traits (Fig. 3)
indicate, however, that some type 2 diabetes risk alleles are
associated with higher, not lower, birth weight, and therefore
may contribute to the other side of the U-shaped curve.
Evidence that Non-genetic Factors Underlie
the Association Between Higher Birth Weight
and Type 2 Diabetes
The association between higher birth weight and type 2 dia-
betes is more apparent in populations with high type 2 diabe-
tes prevalence, for example, the Pima Indian population of
Arizona. In this population, children born to mothers who
showed signs of diabetes in pregnancy had higher birth
weights and higher rates of type 2 diabetes later in life than
those born to non-diabetic mothers [31]. These higher rates of
diabetes might reflect a stronger genetic predisposition, but it
was also observed that the offspring of women who developed
diabetes before pregnancy had a higher prevalence of type 2
diabetes than in those whose mothers developed diabetes after
pregnancy. Exposure to maternal hyperglycemia in utero re-
sults in increased fetal growth as a result of higher fetal insulin
secretion, while shared environmental factors post-birth will
contribute to a higher risk of type 2 diabetes in the offspring.
But the difference between the offspring of prediabetic vs.
diabetic mothers suggests that intrauterine-hyperglycemia ex-
posure additionally contributes to a higher risk of type 2 dia-
betes in later life, likely through an adverse effect on offspring
beta cell function (Fig. 1, right side).
Studies of monogenic diabetes and type 1 diabetes have
provided additional evidence in support of such intrauterine
effects; an 8-year earlier age of diagnosis was observed for
individuals inheriting a diabetes-causing mutation in HNF1A
if this was inherited from their mother (who had diabetes
Fig. 3 Associations of SNPs at nine loci identified in GWAS with birth
weight and type 2 diabetes. a Type 2 diabetes (T2D) odds ratio [1, 21] (y-
axis) plotted against birth weight (BW) effect size in SD units (x-axis) of
SNPs at nine loci implicated in GWAS of both traits. Solid circles indicate
fetal genotype associations for peak (i.e., most strongly associated) SNPs
identified in fetal GWAS of birth weight [20••], while solid triangles
indicate the corresponding maternal genotype associations at the same
SNPs [20••]. Open circles indicate fetal genotype associations for peak
SNPs identified in GWAS of T2D [1, 21–26]. The open triangles indicate
corresponding maternal genotype associations (available only for GCK
[27] andMTNR1B [20••, 27]) at the same (or perfectly-correlated) SNPs.
b Pairwise linkage disequilibrium (LD) estimates (in European samples)
between peak birth weight SNPs [20••] and peak T2D SNPs [1, 21–26] at
the nine loci implicated in both traits. An r2 close to 1 implies that the
peak SNPs for both traits provides almost identical information. For
example, at CDKAL1, MTNR1B, ADCY5, and ANK1, the birth weight
and type 2 diabetes peak SNPs are very closely correlated, so the birth
weight and T2D association signals can be assumed to be tagging the
same causal variant (also likely the case for HHEX-IDE and PEPD,
where r2 ≈ 0.4). Conversely, there is a low correlation between the BW
and T2D peak SNPs at INS-IGF2, GCK, and HMGA2), raising the
possibility that they could be tagging different association signals
within the same region of LD (indicated by D’ of 1). In particular, the
very different birth weight and T2D associations of the two GCK SNPs
support this—the birth weight peak SNP from the fetal GWAS at this
locus (also encompassing YKT6) is of low minor allele frequency
(European MAF <1%) and shows no evidence of association with T2D,
whereas the T2D peak SNP is common (European MAF = 18%), with
some evidence of association between the maternal risk allele and higher
birth weight. The latter is consistent with a primary effect on maternal
hyperglycemia
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while pregnant), than if inherited from their father [32]; and in
a study of the offspring of parents with type 1 diabetes, those
with affected mothers had poorer glucose tolerance and beta
cell function than those with affected fathers [33].
Evidence that Genetic Factors Underlie
the Association Between Higher Birth Weight
and Type 2 Diabetes
As illustrated in Fig. 3, there are examples of individual loci
that show positive associations with both birth weight and
type 2 diabetes risk [20••]. At the MTNR1B locus, both the
fetal and maternal risk allele at SNP rs10830963 have been
identified in GWAS as associated with higher birth weight
[20••, 27]. The maternal effect size is larger than the fetal
effect size at this SNP, and it is likely that the association
observed with the fetal risk allele is merely due to correlation
with the allele in the mother. The risk allele at MTNR1B has
one of the largest effects of common variants known to influ-
ence fasting glucose levels [34], thus the likely mechanism
underlying the birth weight association is of higher fetal insu-
lin secretion in response to higher maternal glucose levels.
Inheritance of the risk allele by the offspring would then ex-
plain the link with the later higher risk of type 2 diabetes.
Similar patterns of association have been observed between
maternal type 2 diabetes risk alleles and higher offspring birth
weight at the GCK and TCF7L2 loci [35–37], both of which
are known to influence fasting glucose levels in adults without
diabetes [23]. However, larger sample sizes will be required to
confirm the birth weight associations with genome-wide
levels of statistical support. The common variant at GCK is
likely to represent an association signal distinct from the near-
by low frequency variant that has been associated with birth
weight when present in the fetus [20] (see Fig. 3).
Finally, variation at one locus, ANK1, shows association
with both higher birth weight and higher risk of type 2 diabe-
tes [20], but unlikeMTNR1B, this association does not appear
to be driven by the maternal genotype, raising the possibility
of a genetic mechanism contributing to the observational as-
sociation between higher birth weight and type 2 diabetes that
operate independently of maternal hyperglycemia.
The Relative Effects on Birth Weight of Genetic
Variants Associated with Type 2 Diabetes Give Clues
to the Timing of their Physiological Effects
The variety of associations observed between known type 2
diabetes variants and birth weight enable us to make a number
of inferences about their mechanisms of action. Of the nine loci
in Fig. 3, those with the largest birth weight-lowering effects
(CDKAL1, ADCY5, HHEX-IDE) also have relatively large
effects on type 2 diabetes risk. These three loci are all classified
as associated with reduced beta cell function [38], and their
associations with birth weight suggest that they may start to
influence insulin secretion during early growth. In notable con-
trast, the fetal risk allele at the common variant locus with the
largest effect on type 2 diabetes risk, TCF7L2, is not associated
with lower birth weight [20], strongly suggesting it confers little
or no insulin secretory defect in fetal life.
Alleles showing the largest effects on raising birth weight
through the maternal genotype (MTNR1B, GCK) are known to
have relatively large effects on fasting glucose and more mod-
erate effects on type 2 diabetes risk. The balance of maternal
birth weight-raising vs. fetal birth weight-lowering effects might
be viewed as a bioassay on the life-course timing of physiolog-
ical effects on beta-cell function. For example, a larger maternal
than fetal effect suggests the allelic effect is less prominent in
early life than in later life. To disentangle the contribution of the
mother’s genotype from that of the offspring, and to estimate
accurately the maternal and fetal effects at individual loci will
require extremely large samples of mother-child pairs.
Future Studies will Require the Analysis of both
Parent and Offspring Genotype Data
GWAS of birth weight have to date focussed solely on either
the fetal or the maternal genotype. This is in part due to the
limited number of studies with comprehensive phenotype and
genotype data on both offspring and parents. To better under-
stand the associations between birth weight and type 2 diabe-
tes and the relative effects of maternal and fetal genotypes on
early development, it will be important to include both mater-
nal and fetal data in the same analyses.
One approach to disentangling maternal from fetal effects is
to define and use the maternally transmitted, non-transmitted
and paternally inherited alleles. In the absence of assortative
mating, the maternal non-transmitted and paternally inherited
alleles should be uncorrelated with the maternal-transmitted
allele, therefore allowing differentiation between maternal and
fetal effects. This has been done successfully using a genetic
score of height-raising alleles in relation to birth weight and
length, showing the predominant importance of transmitted al-
leles [39•]. In future, well-powered studies, this method has the
potential to clarify the role of maternal vs. fetal effects on birth
weight variation and its association with type 2 diabetes.
Type 2 diabetes loci have been identified that express effects
on disease risk in a parent-of-origin specific manner [40]. To
date, no parental origin-specific effects of common genetic var-
iants have been demonstrated for birth weight. However, the
latest fetal GWAS of birth weight observed enrichment of asso-
ciations in imprinted genes and three loci at, or close to,
genome-wide significance encompassed imprinted regions of
the genome (near INS-IGF2, RB1, and DLK1) [20••]. Future
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well-powered studies of parent-offspring trios or mother-child
pairs will enable detection of any underlying parent-of-origin
effects.
Conclusions
The U-shaped association between type 2 diabetes and birth
weight is underpinned by multiple genetic and non-genetic fac-
tors. Recent GWASdata have greatly improved our understand-
ing of the genetic factors contributing to the two traits, provid-
ing examples of individual loci that explain both positive and
inverse covariation between them.Moreover, genome-wide ge-
notype data in individuals with life-course phenotype data has
enabled initial estimates of the overall role of genetic factors,
suggesting they may play a major role in the association be-
tween type 2 diabetes and lower birth weight. Many questions
remain unanswered, however, such as the relative importance
of maternal and fetal genetic effects both genome-wide and at
individual loci, and it is likely that great future gains will be
made from well-powered analyses of parents and offspring.
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